Arena Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 16
A live audio webcast of the presentation will be posted under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event.
It is the breadth and depth of the portfolio, the prioritization of drug development to meet unmet patient needs, the strong financial health and the growing, bold-thinking world-class team that gives Arena the ingredients and passion to build a sustainable, vibrant next generation pharmaceutical company.
Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the upcoming conference and Arena's position, including to develop best-in-disease medicines, Arena's drive, portfolio, prioritization, and financial position, and Arena's team, including its growth, thinking, and ability to build the company. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include those disclosed in Arena's filings with the
Executive Vice President and
Chief Financial Officer
Arena Media Contact:
View original content to download multimedia:http://www.prnewswire.com/news-releases/arena-pharmaceuticals-to-present-at-the-38th-annual-jp-morgan-healthcare-conference-on-january-16-300983179.html